Better Controls for Covid-19 Diagnostics
Engineered recombinant antibodies offer advantages over serum-based controls.
Read MorePosted by Laurie Bonner | Nov 4, 2020 | Covid 19, Immunoassay Reagents & test Kits |
Engineered recombinant antibodies offer advantages over serum-based controls.
Read MorePosted by Melanie Hamilton-Basich | Nov 2, 2020 | Cancer, Molecular Diagnostics |
A Medicare administrative contractor has established coverage of the StrataNGS test for patients with advanced stages (III or IV), recurrent, relapsed, refractory, and/or metastatic solid tumors.
Read MorePosted by Laurie Bonner | Nov 2, 2020 | Molecular Diagnostics, Sexually Transmitted Diseases |
A multiplex assay based on high-resolution melting technology accurately identified antimicrobial resistant determinants in Neisseria gonorrhoeae.
Read MorePosted by Melanie Hamilton-Basich | Oct 29, 2020 | Diabetes & Metabolic Diseases, Prenatal Testing |
A blood test commonly used to detect fetal genetic abnormalities can be modified to help predict complications associated with pregnancy before any symptoms develop, according to UCLA researchers and colleagues.
Read MorePosted by Laurie Bonner | Oct 27, 2020 | Infectious Diseases, Microbiology |
Diagnostics are key to preventing and controlling this growing global threat.
Read More